3

OWNERSHIP DOCUMENT

Company: CRESCENT BIOPHARMA, INC.
Filed: May 11, 2017
Period of Report: May 1, 2017
Accession Number: 0000921895-17-001426

View Document ↗ View on SEC.gov ↗